Acuta Capital Partners as of June 30, 2016
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 63 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Lion Biotechnologies | 12.6 | $26M | 3.2M | 8.10 | |
| Veracyte (VCYT) | 7.7 | $16M | 3.2M | 5.03 | |
| IRIDEX Corporation (IRIX) | 7.2 | $15M | 1.0M | 14.79 | |
| Neuroderm Ltd F | 5.0 | $10M | 634k | 16.25 | |
| Immunomedics | 4.8 | $9.9M | 4.3M | 2.32 | |
| Rrsat Global Comm Ntwrk | 3.8 | $8.0M | 612k | 13.07 | |
| Everyday Health | 3.6 | $7.4M | 945k | 7.88 | |
| CAS Medical Systems | 3.1 | $6.4M | 3.5M | 1.84 | |
| Amicus Therapeutics (FOLD) | 3.0 | $6.3M | 1.2M | 5.46 | |
| Ascendis Pharma A S (ASND) | 3.0 | $6.3M | 473k | 13.27 | |
| iShares Russell 2000 Index (IWM) | 2.8 | $5.7M | 50k | 114.98 | |
| Edge Therapeutics | 2.6 | $5.4M | 530k | 10.11 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $5.0M | 64k | 77.80 | |
| Dermira | 2.4 | $5.0M | 170k | 29.25 | |
| Akebia Therapeutics (AKBA) | 2.2 | $4.5M | 600k | 7.48 | |
| Nabriva Therapeutics | 2.0 | $4.2M | 559k | 7.50 | |
| Sarepta Therapeutics (SRPT) | 1.9 | $4.0M | 210k | 19.07 | |
| Oxford Immunotec Global | 1.8 | $3.8M | 417k | 9.00 | |
| Immunomedics Inc note 4.750% 2/1 | 1.8 | $3.7M | 5.5M | 0.68 | |
| Cempra | 1.7 | $3.5M | 210k | 16.49 | |
| Innocoll Hldgs | 1.5 | $3.1M | 568k | 5.51 | |
| Medivation | 1.4 | $3.0M | 50k | 60.30 | |
| ACADIA Pharmaceuticals (ACAD) | 1.3 | $2.8M | 86k | 32.47 | |
| Tesaro | 1.2 | $2.5M | 30k | 84.07 | |
| Marvell Technology Group | 1.1 | $2.3M | 240k | 9.53 | |
| Insulet Corporation (PODD) | 1.1 | $2.3M | 75k | 30.24 | |
| Insmed (INSM) | 1.0 | $2.2M | 220k | 9.86 | |
| Pacific Biosciences of California (PACB) | 1.0 | $2.1M | 300k | 7.04 | |
| Allergan | 0.9 | $2.0M | 8.5k | 231.06 | |
| Cynapsus Therapeutics | 0.9 | $1.9M | 115k | 16.75 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $1.9M | 42k | 45.45 | |
| Progenics Pharmaceuticals | 0.9 | $1.9M | 449k | 4.22 | |
| Retrophin | 0.8 | $1.8M | 99k | 17.81 | |
| Essa Pharma | 0.8 | $1.8M | 570k | 3.08 | |
| Rigel Pharmaceuticals (RIGL) | 0.8 | $1.7M | 748k | 2.23 | |
| AtriCure (ATRC) | 0.8 | $1.6M | 113k | 14.13 | |
| WebMD Health | 0.7 | $1.5M | 25k | 58.12 | |
| Cytokinetics (CYTK) | 0.6 | $1.3M | 141k | 9.49 | |
| Stone Energy Corp | 0.6 | $1.3M | 108k | 12.06 | |
| Genomic Health | 0.6 | $1.3M | 49k | 25.90 | |
| Ignyta | 0.6 | $1.2M | 230k | 5.42 | |
| Assembly Biosciences | 0.6 | $1.3M | 225k | 5.55 | |
| Alimera Sciences | 0.6 | $1.2M | 974k | 1.23 | |
| Universal Display Corporation (OLED) | 0.5 | $1.0M | 15k | 67.80 | |
| Raptor Pharmaceutical | 0.5 | $938k | 175k | 5.37 | |
| Oncobiologics | 0.4 | $828k | 243k | 3.40 | |
| Sinovac Biotech (SVA) | 0.4 | $786k | 133k | 5.93 | |
| Mirati Therapeutics | 0.3 | $683k | 125k | 5.46 | |
| Ironwood Pharmaceuticals (IRWD) | 0.3 | $654k | 50k | 13.08 | |
| Biotelemetry | 0.3 | $564k | 35k | 16.29 | |
| Akari Therapeutics | 0.2 | $446k | 33k | 13.48 | |
| Caredx (CDNA) | 0.1 | $279k | 65k | 4.32 | |
| Cytrx | 0.1 | $223k | 100k | 2.23 | |
| Trovagene | 0.1 | $236k | 52k | 4.54 | |
| Dextera Surgical | 0.1 | $232k | 129k | 1.80 | |
| Audiocodes Ltd Com Stk (AUDC) | 0.1 | $189k | 45k | 4.20 | |
| Relypsa | 0.1 | $185k | 10k | 18.50 | |
| Combimatrix Corporation | 0.1 | $136k | 47k | 2.87 | |
| MannKind Corporation | 0.1 | $104k | 90k | 1.16 | |
| Chembio Diagnostics | 0.1 | $100k | 12k | 8.21 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $45k | 97k | 0.46 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $44k | 97k | 0.45 | |
| Pernix Therapeutics Holdings | 0.0 | $28k | 63k | 0.45 |
